1Institute of Behavioural Physiology,Leibniz Institute for Farm Animal Biology,D-18196 Dummerstorf,Germany.
2Institute of Genetics and Biometry,Leibniz Institute for Farm Animal Biology,D-18196 Dummerstorf,Germany.
Animal. 2018 Jan;12(1):116-121. doi: 10.1017/S1751731117001197. Epub 2017 May 30.
Immune competence can be tested by challenging organisms with a set of infectious agents. However, disease control requirements impose restrictions on the infliction of infections upon domestic pigs. Alternatively, vaccinations induce detectable immune responses that reflect immune competence. Here, we tested this approach with tetanus toxoid (TT) in young domestic pigs. To optimize the vaccination protocol, we immunized the pigs with a commercial TT vaccine at the age of 21 or 35 days. Booster immunizations were performed either 14 or 21 days later. TT-specific antibodies in plasma as well as lymphoproliferative responses were determined both 7 and 14 days after booster immunization using ELISA and lymphocyte transformation tests, respectively. In addition, general IgG and IgM plasma concentrations and mitogen-induced proliferation were measured. The highest TT-specific antibody responses were detected when blood samples were collected 1 week after a booster immunization conducted 21 days after primary immunization. The pigs' age at primary immunization did not have a significant influence on TT-specific antibody responses. Similarly, the TT-specific proliferative responses were highest when blood samples were collected 1 week after booster immunization, while age and time of primary and booster immunization were irrelevant in our setup. While general IgG and IgM plasma levels were highly age dependent, there were no significant age effects for TT-specific immune responses. In addition, mitogen-induced proliferation was independent of immunization as well as blood sampling protocols. In summary, our model of TT vaccination provides an interesting approach for the assessment of immune competence in young pigs. The detected vaccination effects were not biased by age, even though our data were acquired from immune systems that were under development during our tests.
免疫能力可以通过用一组传染性病原体挑战生物体来测试。然而,疾病控制的要求对家猪的感染施加了限制。另一方面,疫苗接种会引起可检测的免疫反应,反映免疫能力。在这里,我们用破伤风类毒素 (TT) 在年轻的家猪身上测试了这种方法。为了优化疫苗接种方案,我们在 21 或 35 天大时用商业 TT 疫苗对猪进行免疫。14 或 21 天后进行加强免疫。在加强免疫后 7 天和 14 天,分别使用 ELISA 和淋巴细胞转化试验来确定 TT 特异性抗体在血浆中的反应以及淋巴细胞增殖反应。此外,还测量了总 IgG 和 IgM 血浆浓度以及有丝分裂原诱导的增殖。当在初次免疫后 21 天进行的加强免疫后 1 周采集血样时,检测到最高的 TT 特异性抗体反应。初次免疫时猪的年龄对 TT 特异性抗体反应没有显著影响。同样,当在加强免疫后 1 周采集血样时,TT 特异性增殖反应最高,而在我们的设置中,初次和加强免疫的时间和年龄无关。虽然总 IgG 和 IgM 血浆水平高度依赖于年龄,但 TT 特异性免疫反应没有显著的年龄影响。此外,丝裂原诱导的增殖与免疫和采血方案无关。总之,我们的 TT 疫苗接种模型为评估仔猪的免疫能力提供了一个有趣的方法。即使我们的数据是在测试期间免疫系统正在发育的情况下获得的,但检测到的疫苗接种效果不受年龄的影响。